Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neel S Raval

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
The Journal of Investigative Dermatology|April 24, 2022
SnapshotDx Quiz: May 2022Jordan Phillipps, Neel S Raval, Amy Musiek
Pediatric Dermatology|October 14, 2025
A Newborn With a Red-Brown Nasal MassNeel S Raval, Bryan A Sisk, D Ashley Hill, et al.
Clinical Genitourinary Cancer|November 3, 2020
Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular TumorsNicholas A Pickersgill, Neel S Raval, Eric H Kim, et al.
Frontiers in Medicine|March 6, 2023
Objective response to immune checkpoint inhibitor therapy in <i>NRAS</i>-mutant melanoma: A systematic review and meta-analysisZachary J Jaeger, Neel S Raval, Natalia K A Maverakis, et al.
JAAD Case Reports|December 17, 2021
Alopecia areata after mogamulizumab treatmentNeel S Raval, Nora A Alexander, Karlee De Monnin, et al.
Urology|February 27, 2019
The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical FactorsNicholas A Pickersgill, Joel M Vetter, Neel S Raval, et al.
Journal of the American Academy of Dermatology|November 23, 2021
Racial and socioeconomic differences in acral lentiginous melanoma outcomes: A Surveillance, Epidemiology, and End Results analysisNeel S Raval, Wesley T Hodges, Pearl O Ugwu-Dike, et al.
European Journal of Dermatology : EJD|February 2, 2022
Scarring alopecia developing after mogamulizumab-associated rashNeel S Raval, Caroline K Snowden, Karlee S De Monnin, et al.
JAMA Dermatology|January 12, 2022
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 TherapyKimberly Tang, Jayhyun Seo, Bruce C Tiu, et al.
The Journal of Clinical Investigation|January 2, 2025
T helper 2 cell-directed immunotherapy eliminates precancerous skin lesionsTomonori Oka, Sabrina S Smith, Heehwa G Son, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
The Journal of Investigative Dermatology|April 24, 2022
SnapshotDx Quiz: May 2022Jordan Phillipps, Neel S Raval, Amy Musiek
Pediatric Dermatology|October 14, 2025
A Newborn With a Red-Brown Nasal MassNeel S Raval, Bryan A Sisk, D Ashley Hill, et al.
Clinical Genitourinary Cancer|November 3, 2020
Post-chemotherapy Laparoscopic Retroperitoneal Lymph Node Dissection for Mixed Malignant Germ Cell Testicular TumorsNicholas A Pickersgill, Neel S Raval, Eric H Kim, et al.
Frontiers in Medicine|March 6, 2023
Objective response to immune checkpoint inhibitor therapy in <i>NRAS</i>-mutant melanoma: A systematic review and meta-analysisZachary J Jaeger, Neel S Raval, Natalia K A Maverakis, et al.
JAAD Case Reports|December 17, 2021
Alopecia areata after mogamulizumab treatmentNeel S Raval, Nora A Alexander, Karlee De Monnin, et al.
Urology|February 27, 2019
The Accuracy of Prostate Magnetic Resonance Imaging Interpretation: Impact of the Individual Radiologist and Clinical FactorsNicholas A Pickersgill, Joel M Vetter, Neel S Raval, et al.
Journal of the American Academy of Dermatology|November 23, 2021
Racial and socioeconomic differences in acral lentiginous melanoma outcomes: A Surveillance, Epidemiology, and End Results analysisNeel S Raval, Wesley T Hodges, Pearl O Ugwu-Dike, et al.
European Journal of Dermatology : EJD|February 2, 2022
Scarring alopecia developing after mogamulizumab-associated rashNeel S Raval, Caroline K Snowden, Karlee S De Monnin, et al.
JAMA Dermatology|January 12, 2022
Association of Cutaneous Immune-Related Adverse Events With Increased Survival in Patients Treated With Anti-Programmed Cell Death 1 and Anti-Programmed Cell Death Ligand 1 TherapyKimberly Tang, Jayhyun Seo, Bruce C Tiu, et al.
The Journal of Clinical Investigation|January 2, 2025
T helper 2 cell-directed immunotherapy eliminates precancerous skin lesionsTomonori Oka, Sabrina S Smith, Heehwa G Son, et al.
Pageof 2